1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6211)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13088)
  2. Department of Medicine (13004)
  3. Center for Hematologic Malignancies (10395)
  4. GSK Faculty (4422)
  5. Adult Leukemia (3583)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (775)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (204)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (431)

More Publishers

Results (13088)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting novel antigens for prostate cancer treatment: Focus on prostate-specific membrane antigen
    Journal Article

    Slovin, S. F.
    Expert Opinion on Therapeutic Targets (2005)

    Fulltext@MSK | Save
  • Prostate-specific membrane antigen vaccines: Naked DNA and protein approaches
    Journal Article

    Slovin, S. F.
    Clinical Prostate Cancer (2005)

    Fulltext@MSK | Save
  • Fifth International Prostate Cancer Congress. 1-3 July 2005, Rio Grande, Puerto Rico
    Journal Article

    Slovin, S. F.
    IDrugs (2005)

    Fulltext@MSK | Save
  • Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
    Journal Article

    Schoder, H.; Noy, A.; Gonen, M.; Weng, L.; Green, D.; Erdi, Y. E.; Larson, S. M.; Yeung, H. W. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Immune surveillance of leukemia?
    Journal Article

    Scheinberg, D. A.
    Haematologica (2005)

    Fulltext@MSK | Save
  • Progress toward the genetic treatment of the β-thalassemias
    Conference Paper

    Sadelain, M.; Lisowski, L.; Samakoglu, S.; Rivella, S.; May, C.; Riviere, I.
    John Wiley & Sons (2005)

    Fulltext@MSK | Save
  • Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity
    Journal Article

    Rossi, M.; Young, J. W.
    Journal of Immunology (2005)

    Fulltext@MSK | Save
  • Should radioimmunotherapy be an initial treatment option in advanced-stage follicular lymphoma? Commentary
    Journal Article

    Portlock, C. S.
    Nature Clinical Practice Oncology (2005)

    Fulltext@MSK | Save
  • Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses
    Journal Article

    Pinilla-Ibarz, J.; Korontsvit, T.; Zakhaleva, V.; Roberts, W.; Scheinberg, D. A.
    Haematologica (2005)

    Fulltext@MSK | Save
  • Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses
    Journal Article

    Perales, M. A.; Chapman, P. B.
    Cancer Chemotherapy and Biological Response Modifiers (2005)

    Fulltext@MSK | Save